GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
May 29, 2024 08:00 ET
|
Genetic Technologies Ltd
Genetic Technologies Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
GeneType and Humanise Health host “Know Your Risk” Event
May 23, 2024 08:00 ET
|
Genetic Technologies Ltd
"Know Your Risk" Event a remarkable success in Pasadena.
GTG to pilot GeneType in Breast Screen centers across the U.S.
April 11, 2024 08:00 ET
|
Genetic Technologies Ltd
Genetic Technologies to pilot GeneType in Breast Screen centers across the U.S.
GeneType featured on U.S. National TV to raise Breast Cancer Awareness
May 23, 2023 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, May 23, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious...
Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease
November 10, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies (ASX:GTG, NASDAQ:GENE), a global leader in guideline driven Genomics based tests in health, wellness and serious disease...
GeneType Risk Assessment Test onboarding in 16 clinics
July 01, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Transformational Pathway to US Payer System; Attributing US$1.4 Billion Health and Economic Benefit from geneType Breast Cancer Risk Assessment Test
June 16, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, June 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Pathnova Laboratories (PATHNOVA) Enters into Partnership to Commercialize Todos Medicals COVID-19 and Breast Cancer Tests in Singapore
August 03, 2020 07:00 ET
|
Todos Medical Ltd.
Temasek Life Sciences Accelerator-backed PATHNOVA to Offer COVID-19 Testing Kits Supplied by Todos in Singapore and Southeast Asia REHOVOT, Israel, SINGAPORE and NEW YORK, NY, Aug. 03, 2020 ...
CONTEMPORARY OBSTETRICS AND GYNECOLOGY OF DAYTON ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
September 30, 2013 10:34 ET
|
Genetic Technologies Group
DAYTON, Ohio, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Contemporary Obstetrics & Gynecology, part of the Providence Medical Group, today announced the availability of the BREVAGen™ predictive risk...
Atossa Genetics to Present at the 2013 Aegis Capital Healthcare Conference
September 24, 2013 10:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 24, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, Chief Financial Officer & General Counsel,...